AChE is responsible for the hydrolysis of acetylcholine (ACh), an important compound in neurotransmission (associated with learning and memory functions), thus the use of AChE inhibitors is one of the currently available treatment options for Alzheimer’s disease [55]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.